BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22425593)

  • 1. Presentation of an unusual patient with Lafora disease.
    Gökdemir S; Cağlayan H; Kızıltan M; Karaağaç N; Leblebici C; Yeni SN
    Epileptic Disord; 2012 Mar; 14(1):94-8. PubMed ID: 22425593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lafora disease: a case report, pathologic and genetic study.
    Harirchian MH; Shandiz EE; Turnbull J; Minassian BA; Shahsiah R
    Indian J Pathol Microbiol; 2011; 54(2):374-5. PubMed ID: 21623095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progressive myoclonic epilepsy type Lafora].
    Chemaly R; Checrallah A; Trak-Smayra V; El-Kallab K; Chemaly E
    J Med Liban; 2001; 49(3):170-2. PubMed ID: 12187920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lafora disease: histopathological study of axillary cutaneous biopsy].
    Mnif H; Ksentini M; Gheriani M; Charfi S; Kallel R; Makni S; Boudawara TS
    Ann Pathol; 2013 Apr; 33(2):84-6. PubMed ID: 23582833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Typical progression of myoclonic epilepsy of the Lafora type: a case report.
    Striano P; Zara F; Turnbull J; Girard JM; Ackerley CA; Cervasio M; De Rosa G; Del Basso-De Caro ML; Striano S; Minassian BA
    Nat Clin Pract Neurol; 2008 Feb; 4(2):106-11. PubMed ID: 18256682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lafora disease. A new case of confirmation of diagnosis on molecular genetic studies].
    Martínez-Bermejo A; López-Martín V; Serratosa JM; Gutiérrez-Molina M; Gómez-Garre P; Arcas J; Tendero A; Roche C; Pérez-Mies B
    Rev Neurol; 2002 Jan 16-31; 34(2):117-20. PubMed ID: 11988905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe and rapidly-progressive Lafora disease associated with NHLRC1 mutation: a case report.
    Casciato S; Gambardella S; Mascia A; Quarato PP; D'Aniello A; Ackurina Y; Albano V; Fornai F; Scala S; Di Gennaro G
    Int J Neurosci; 2017 Dec; 127(12):1150-1153. PubMed ID: 28556688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Myoclonic epilepsy of Lafora: a case report].
    Rudenskaia GE; Zakharova EIu; Karpin SL; Uchaev DA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(3 Suppl 2):11-6. PubMed ID: 20873469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapidly progressive phenotype of Lafora disease associated with a novel NHLRC1 mutation.
    Brackmann FA; Kiefer A; Agaimy A; Gencik M; Trollmann R
    Pediatr Neurol; 2011 Jun; 44(6):475-7. PubMed ID: 21555062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and genetic studies in patients with Lafora disease from Pakistan.
    Ahmad A; Dad R; Ullah MI; Baig TA; Ahmad IN; Nasir A; Hübner CA; Hassan MJ
    J Neurol Sci; 2017 Feb; 373():263-267. PubMed ID: 28131202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Late discovery of Lafora disease: a family study].
    Messouak O; Yahyaoui M; Benabdeljalil M; Benomar A; Ouazzani R; Amarti A; Saidi A; Chkili T
    Rev Neurol (Paris); 2002 Jan; 158(1):74-6. PubMed ID: 11938326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lafora disease.
    Madhavan D; Kuzniecky RI
    Rev Neurol Dis; 2006; 3(3):131-5. PubMed ID: 17047580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 22-year-old girl with status epilepticus and progressive neurological symptoms.
    Striano P; Ackerley CA; Cervasio M; Girard JM; Turnbull J; Del Basso-De Caro ML; Striano S; Zara F; Minassian BA
    Brain Pathol; 2009 Oct; 19(4):727-30. PubMed ID: 19744044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lafora disease presentation, two cases in a Mexican family].
    González-De la Rosa MG; Alva-Moncayo E
    Rev Med Inst Mex Seguro Soc; 2017; 55(2):252-256. PubMed ID: 28296376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational spectrum of the EPM2A gene in progressive myoclonus epilepsy of Lafora: high degree of allelic heterogeneity and prevalence of deletions.
    Gómez-Garre P; Sanz Y; Rodríguez De Córdoba SR; Serratosa JM
    Eur J Hum Genet; 2000 Dec; 8(12):946-54. PubMed ID: 11175283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of levetiracetam in refractory seizures due to a rare progressive myoclonic epilepsy: Lafora body disease.
    Hashmi M; Saleem F; Mustafa MS; Sheerani M; Ehtesham Z; Siddiqui K
    BMJ Case Rep; 2010 Nov; 2010():. PubMed ID: 22791845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive myoclonus epilepsy with polyglucosan bodies: Lafora disease.
    Minassian BA
    Adv Neurol; 2002; 89():199-210. PubMed ID: 11968446
    [No Abstract]   [Full Text] [Related]  

  • 18. A case of Lafora's disease associated with cardiac arrhythmia.
    Oksel F; Tekgül H; Genç S; Ozyürek R; Akalin T; Tütütüncüoğlu S
    J Child Neurol; 1999 Nov; 14(11):745-6. PubMed ID: 10593553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRKCG mutation (SCA-14) causing a Ramsay Hunt phenotype.
    Visser JE; Bloem BR; van de Warrenburg BP
    Mov Disord; 2007 May; 22(7):1024-6. PubMed ID: 17343273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioptically demonstrated Lafora disease without EPM2A mutation: a clinical and neurophysiological study of two sisters.
    Boccella P; Striano P; Zara F; Barbieri F; Sarappa C; Vacca G; de Falco FA; Striano S
    Clin Neurol Neurosurg; 2003 Dec; 106(1):55-9. PubMed ID: 14643920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.